ANALYTIXINSIGHT INC (ALY.CA)

CA03268Y1060 - Common Stock

0.02  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALY. ALY was compared to 69 industry peers in the Software industry. The financial health of ALY is average, but there are quite some concerns on its profitability. ALY does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALY has reported negative net income.
ALY had a negative operating cash flow in the past year.
ALY had negative earnings in each of the past 5 years.
In the past 5 years ALY always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -141.16%, ALY is not doing good in the industry: 80.88% of the companies in the same industry are doing better.
ALY has a Return On Equity of -219.38%. This is in the lower half of the industry: ALY underperforms 66.18% of its industry peers.
Industry RankSector Rank
ROA -141.16%
ROE -219.38%
ROIC N/A
ROA(3y)-59.12%
ROA(5y)-48.59%
ROE(3y)-68.71%
ROE(5y)-55.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ALY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

ALY does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALY has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALY has been increased compared to 5 years ago.
ALY has a better debt/assets ratio than last year.

2.2 Solvency

ALY has an Altman-Z score of -17.28. This is a bad value and indicates that ALY is not financially healthy and even has some risk of bankruptcy.
ALY's Altman-Z score of -17.28 is on the low side compared to the rest of the industry. ALY is outperformed by 75.00% of its industry peers.
ALY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.28
ROIC/WACCN/A
WACC10.58%

2.3 Liquidity

A Current Ratio of 0.07 indicates that ALY may have some problems paying its short term obligations.
With a Current ratio value of 0.07, ALY is not doing good in the industry: 95.59% of the companies in the same industry are doing better.
A Quick Ratio of 0.07 indicates that ALY may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.07, ALY is doing worse than 95.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07

More info and screens

0

3. Growth

3.1 Past

ALY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.45%.
ALY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -81.60%.
ALY shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.17% yearly.
EPS 1Y (TTM)-36.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.66%
Revenue 1Y (TTM)-81.6%
Revenue growth 3Y-45.57%
Revenue growth 5Y-36.17%
Sales Q2Q%-76.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANALYTIXINSIGHT INC

TSX-V:ALY (12/24/2024, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-27 2024-11-27
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.07%
Ins Owner ChangeN/A
Market Cap1.93M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.75
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -141.16%
ROE -219.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.12%
ROA(5y)-48.59%
ROE(3y)-68.71%
ROE(5y)-55.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -17.28
F-ScoreN/A
WACC10.58%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.66%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-81.6%
Revenue growth 3Y-45.57%
Revenue growth 5Y-36.17%
Sales Q2Q%-76.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.7%
OCF growth 3YN/A
OCF growth 5YN/A